A plain-language guide

granulomatosis with polyangiitis

What is known, what is still uncertain, and what is actively debated, written plainly, and built only from published medical research.

Early map · 10 sourced statements Every statement names its source Updated 2026-06-12
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. granulomatosis with polyangiitis is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What it is

Granulomatosis with polyangiitis (GPA) is a rare disease in which the immune system inflames and damages small to medium-sized blood vessels. Because those vessels run throughout the body, GPA can affect several organs at once, most often the sinuses and airways, the lungs, and the kidneys.

Signs and symptoms

Pulmonary nodule

GPA can produce nodules (rounded spots) in the lungs, sometimes with a hollow center, which is why a chest scan is often part of the work-up.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42158786
Notesplain_language confirmed from PMID:42158786 via curation 2026-06-12.
Last reviewed2026-06-12

Hemoptysis

Coughing up blood (hemoptysis) can occur when GPA inflames the lungs' blood vessels. It is a symptom to report to a clinician promptly.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42158786
Notesplain_language confirmed from PMID:42158786 via curation 2026-06-12.
Last reviewed2026-06-12

Cytoplasmic antineutrophil antibody positivity

Most people with GPA carry a specific autoantibody in their blood, c-ANCA, which a lab test can detect. A positive result helps point to the diagnosis.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42158786
Notesplain_language confirmed from PMID:42158786 via curation 2026-06-12.
Last reviewed2026-06-12

Anti-proteinase 3 antibody positivity

The c-ANCA in GPA is usually aimed at a protein called proteinase-3 (PR3). A blood test showing anti-PR3 antibodies strengthens the case for GPA.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42164191
Notesplain_language confirmed from PMID:42164191 via curation 2026-06-12.
Last reviewed2026-06-12

Hematuria

Blood in the urine (hematuria), often together with protein, can be an early sign that GPA is affecting the kidneys, even before symptoms are obvious.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42113751
Notesplain_language confirmed from PMID:42113751 via curation 2026-06-12.
Last reviewed2026-06-12

Glomerulonephritis

GPA often inflames the kidney's tiny filters (glomerulonephritis), which can show up as blood or protein in the urine and, if unchecked, can reduce kidney function.

Limited evidenceSource: ORPHA:900
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42113751
Notesplain_language confirmed from PMID:42113751 via curation 2026-06-12.
Last reviewed2026-06-12

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

Cyclophosphamide

Cyclophosphamide is a long-established immune-suppressing medicine used to bring active GPA under control (remission induction). It is one of the standard options a specialist may use for serious disease.

Used to help with: Granulomatosis with polyangiitis.

Limited evidenceSource: PMID:42100069
The source text this rests on
“Cyclophosphamide remains a cornerstone of remission induction therapy in granulomatosis with polyangiitis…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42100069 via curation 2026-06-12
Last reviewed2026-06-12

Turn this into questions for your doctor

The hardest part is often knowing what to ask. PatientLead Health helps families turn what is on this page into the right questions for their care team.

Prepare for your appointment with PatientLead Health →

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.

Where this comes from

This guide is built from 3 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

ORPHA:900 · Orphanet/HPO annotations for Granulomatosis with polyangiitis
PMID:42100069 · Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study.
PMID:42253887 · PR3-ANCA-associated vasculitis (granulomatosis with polyangiitis / Wegener's)